I think the stock will recover. |
The interaction of these drugs is not clearly understood. |
The long-term effects of that are not known. Many docs have said they'd be cautious prescribing it at first. |
The quality of the earnings was not great. Usually they beat [expectations] in the fourth quarter. |
They've had lighter [numbers] in the past two quarters. There might have been some inventory fluctuations that would actually help them and have a small impact on sales numbers on the positive side. Otherwise, I'm expecting numbers to be in line with consensus. |